Note: Ingredients listed on restricted chemical lists
EC/CAS
100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
202-859-9
Name of the chemical
Benzyl alcohol (38)
Concentration
N/A
EC/CAS
231-791-2
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2010-04-09
Product name
Lincocin Injection
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance: Liquid
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term: May cause eye, skin and respiratory tract irritation. Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Known Clinical Effects: The most common adverse effects reported with clinical use were diarrhea, nausea, rash, and vomiting. Effects on blood and blood-forming organs have also occurred. This compound can cross the placenta in pregnant women. Secreted in human breast milk. EU Indication of danger: Not classified Australian Hazard Classification Non-Hazardous Substance. Non-Dangerous Goods. (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
